We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Damaged DNA Spotter Protein Purified

By Biotechdaily staff writers
Posted on 09 Jun 2002
A protein called ATR that preferentially binds to damaged DNA has been purified, and it appears to function as an initial sensor for injury to genetic material. More...
The ATR protein is a member of the phosphatidylinositol kinase-related family. Details of purification of the protein and subsequent biochemical and electron microscope analysis have been published in the May 14, 2002, edition of the Proceedings of the National Academy of Sciences.

Researchers at the University of North Carolina (UNC, Chapel Hill, USA) have found that ATR binds to UV-damaged DNA with higher affinity than to undamaged DNA. Furthermore, damaged DNA stimulates the kinase activity of ATR to a significantly higher degree than does undamaged DNA. Damage to DNA may be caused by such agents as pollution, ultraviolet radiation, and chemotherapy.

The downstream effects of the ATR alarm protein were already known, but it was not clear whether ATR sensed damaged DNA directly or was simply part of the cascade of repair activated by another protein upstream. The results of the current study suggest that ATR senses damaged DNA and also helps start the cascade.

"This is a very important phenomenon in both normal and cancerous cells, and there has been a great deal of research about it,” said Dr. Aziz Sancar, professor of microbiology and immunology at UNC. "ATR appears to act as a switch that starts the repair process and also stops cells from proliferating while they are being repaired. This new work is not going to cure cancer by itself, but it is a significant step forward.”



Related Links:
University of North Carolina

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.